155 related articles for article (PubMed ID: 8525533)
1. Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine.
Hartner WC; Van der Werf WJ; Lodge JP; Gilchrist B; De Fazio SR; Markees TG; Yatko C; Monaco AP; Gozzo JJ
Transplantation; 1995 Dec; 60(11):1347-50. PubMed ID: 8525533
[TBL] [Abstract][Full Text] [Related]
2. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
3. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
5. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ
Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin: immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model.
Almond PS; Moss A; Nakhleh RE; Melin M; Chen S; Salazar A; Shirabe K; Matas AJ
Transplantation; 1993 Aug; 56(2):275-81. PubMed ID: 8356580
[TBL] [Abstract][Full Text] [Related]
7. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
[TBL] [Abstract][Full Text] [Related]
9. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
Robertson A; Plenter R; Francis DM; Clunie GJ
Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
[No Abstract] [Full Text] [Related]
10. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
12. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
[TBL] [Abstract][Full Text] [Related]
13. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
[TBL] [Abstract][Full Text] [Related]
14. Cardiac allograft tolerance induction with limited immunosuppression.
Cohen DS; Fisher RA; Tarry WC; Tawes JW
J Surg Res; 1996 Mar; 61(2):355-60. PubMed ID: 8656608
[TBL] [Abstract][Full Text] [Related]
15. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
16. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclosporine A treatment on induction of donor specific unresponsiveness in mongrel dogs following a short course of ALS and donor bone marrow infusion on canine renal allograft function.
Hartner WC; Shaffer D; Markees TG; De Fazio SR; Monaco AP; Gozzo JJ
Transplant Proc; 1991 Feb; 23(1 Pt 1):477-9. PubMed ID: 1990590
[No Abstract] [Full Text] [Related]
18. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
De Fazio SR; Plowey J; Hartner WC; Gozzo JJ
Transplant Proc; 1994 Dec; 26(6):3102-3. PubMed ID: 7998084
[No Abstract] [Full Text] [Related]
19. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
